GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Compass Pathways PLC (FRA:5Y6) » Definitions » Institutional Ownership

Compass Pathways (FRA:5Y6) Institutional Ownership : 7.82% (As of Jun. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Compass Pathways Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Compass Pathways's institutional ownership is 7.82%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Compass Pathways's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Compass Pathways's Float Percentage Of Total Shares Outstanding is 0.00%.


Compass Pathways Institutional Ownership Historical Data

The historical data trend for Compass Pathways's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Compass Pathways Institutional Ownership Chart

Compass Pathways Historical Data

The historical data trend for Compass Pathways can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 12.04 11.68 9.95 10.02 10.63 10.04 9.77 7.87 7.92 7.82

Compass Pathways Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Compass Pathways (FRA:5Y6) Business Description

Traded in Other Exchanges
Address
33 Broadwick Street, London, GBR, W1F 0DQ
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Compass Pathways (FRA:5Y6) Headlines

No Headlines